Table 2.
Surgical details by study group
| Characteristic | No. (%) of patients;* residence | p value | |
|---|---|---|---|
| Urban and suburban n = 219 |
Rural and remote n = 55 |
||
| Surgery | 0.96 | ||
| Curative intent | 139 (63) | 36 (65) | |
| Palliative | 33 (15) | 8 (15) | |
| None | 47 (21) | 11 (20) | |
| Time from diagnosis to surgery, d, median (IQR) | 71 (35–125) | 86 (34–121) | 0.91 |
| Approach | 0.36 | ||
| Minimally invasive | 56 (26) | 14 (25) | |
| Open | 110 (49) | 29 (52) | |
| Converted | 5 (2) | 3 (5) | |
| Procedure | 0.21 | ||
| Subtotal gastrectomy | 93 (42) | 23 (42) | |
| Total gastrectomy | 50 (23) | 14 (25) | |
| Proximal gastrectomy | 10 (5) | 4 (7) | |
| Extended total gastrectomy | 12 (3) | 5 (9) | |
| Gastrojejunal bypass | 3 (1) | 0 (0) | |
| Feeding jejunostomy | 3 (1) | 0 (0) | |
| Surgery duration, min, median (IQR) | 161 (137–187) | 164 (150–191) | 0.33 |
| Estimated blood loss, mL, median (IQR) | 200 (100–400) | 350 (138–625) | 0.11 |
| Length of stay, d, median (IQR) | 6 (4–10) | 6 (5–7) | 0.50 |
| 30-day complications | 0.55 | ||
| CD 0 | 65 (30) | 20 (36) | |
| CD 1–2 | 66 (30) | 19 (35) | |
| CD 3–4 | 35 (16) | 8 (15) | |
| CD 5 | 6 (3) | 0 (0) | |
CD = Clavien–Dindo score; IQR = interquartile range.
*
Unless indicated otherwise.